Abstract:Objective To evaluate the therapeutic effect and possible mechanism of intrapleural administra- tion of cisplatin bound to activated carbon particles for treating malignant pleura] effusions(MPE). Methods ①60 patients with MPE confirmed in the Third Hospital of Changzhou and the Second Hospital of Changzhou from 2004 to 2007 were randomly divided into treatment group (n=30)and control group(n=30). Chest catheters were inserted percutaneously into the pleural space to drain the effusions. Cisplatin mixed with activated carbon particles for the treatment group and only cisplatin for the control group were injected into pleural cavity. Whether above-mentioned treatment should be repeated was determined by ultrasonic B every week until up to four times. Curative effect and side-effect were compared between two groups a month later. ②20 cases, randomly selected from both groups respectively, underwent whole body and chest SPECT scan to image lymphatic system by means of 99Tcm-DX after effusions drainage but before intrapleural injection of drug. Cases whose imaging graphics were abnormal would undergo the above SPECT again 2 weeks after intrapleural injection of drug so as to find changes in imaging graphics. Results ① The overall response rate was significantly higher in treatment group than in control group(100% (30/30) vs 66.7% (20/30), χ2=12.00, P<0.01)and that intrapleural injection was needed only once in most cases. Gastrointestinal upset and leucoponia were less and milder in treatment group than in control group (16.7% (5/30) vs 30.0% (9/30) and 6.7% (2/30) vs 20.0% (6/30) respectively),but there was no statistical difference between the two groups(χ2=1.49 and 1.30,P>0.05). ②The rate of improvement in lymphatic imaging was significantly higher in treatment group than in control group (78.6% (11/14) vs 37.5% (6/16),P<0.05). Conclusion The treatment of malignant pleural effusions with intrapleural administration of cisplatin bound to activated carbon particles is extremely effective and safe, and can improve lymphatic drainage as well.

Intracavity Treatment with DDP and Biological Response Modifiers(BRM) for Malignant Pleural Effusions of Ascites

Intracatheter Injection of IL-2 and DDP Combined with Closed Thoracic Drainage in Treatment of Malignant Pleural Effusion

Efficacy Study of Hyperthermotherapy Combined with Cisplatin Injected into Thoracic Cavity in the Treatment of Pleural Effusion from Malignant Neoplams

Effects of intrapleural therapy on 96 patients with malignant pleural effusion

Effect of Interleukin-2 and PDD in Treatment of Malignant Pleural Effu Sion

Therapeutic Effect and Mechanism of Intrapleural Administration of Cisplatin Bound to Activated Carbon Particles for Treating Malignant Pleural Effusion

Evaluating the effect of united treatment of malignancy pleural effusion with closed drainage with self- restraint 10F canal and injecting pleural cavity of medicine

Clinical Observation on Treatment of Malignant Pleural Efusion Caused by Iung Cancer with Intracavity Drainage Plus Perfusion Medication

Hyperthermia combined with intracavitary injection of drug for malignant pleural effusion

Treatment of Malignant Pleural Effusion with Radiofrequency Hyperthermia Combined with Intravenous Chemotherapy and Intrapleural Injection

Clinical Reserch of Therapy Combined with Thermotherapy Plus Kanglaite and Cisplation in the Treatment of Malignant Pleural Effusion

Analysis of intraperitoneal hyperthermic chemoperfusion combined with interleukin-2 in the treatment of malignant ascites

Observation of using microtrauma method with central venous catheter in the indwelling drainage and treatment for malignant pleural effusion by intrapleural injection drugs

Therapeutical Effect of Intrapleural Perfusion with Hyperthermic Chemotherapy on Malignant Pleural Effusion under Video-Assisted Thoracoscopic Surgery

Tunnelled Pleural Catheter Insertions and Intrapleural Administration of Drugs for Malignant Pleural Effusion: a Clinical Control Study

Clinical Analysis of Inserting Abel Central Venous Catheter into Pleural Cavity and Interrupted Pleural Cavity Puncture to Draw Pleural Effusion in the Treatment of Patients with Malignant Pleural Effusion

Intrapleural Chemo- and Hyperthermotherapies for Malignant Pleural Effusion: A Randomized Prospective Study

Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion

Improved Percutaneous Placement Catheters Drainage of Thoracocentesis Accompanying with Intracavitary Chemotherapy for the Treatment of Malignant Pleural Effusion

The Clinical Effects Of Dendritic Cell Vaccines Combined With Cytokine-Induced Killer Cells Intraperitoneal Injected On Patients With Malignant Ascites

Clinical Observation on Intrapleural Administration of Cisplatin and IL-2 Combined with Systemic Chemotherapy in the Treatment of Malignant Pleural Effusion of Lung Cancer